&w=3840&q=100)
Sun Pharma Advanced Research hits 20% lower band; what's rattling Street?
Sun Pharma Advanced Research Company (SPARC) shares slumped 20 per cent in trade on Wednesday, June 4, 2025, hitting its lower circuit at ₹156.5 per share on BSE. The stock was under pressure after the company's partner Sun Pharmaceutical Industries informed that its phase 2 trial for evaluating SOLARES PsO and SOLARES AD studies failed to meet the primary endpoint.
In the past one year, Sun Pharma Advanced Research Company shares have declined 3 per cent as compared to Sensex's rise of around 12 per cent.
At 9:36 AM, Sun Pharma Advanced Research share price was down 15.16 per cent at ₹165.95 per share on the BSE. In comparison, the BSE Sensex was up 0.04 per cent at 80,766.66. The market capitalisation of the company stood at ₹5,385.44 crore. The 52-week high of the stock was at ₹257.7 per share and the 52-week low of the stock was at ₹109.2 per share.
Why did Sun Pharma Advanced Research stock tanked?
The company released a filing on Tuesday, after market hours, in which it said that the phase 2 clinical trials evaluating Vibozilimod (SCD-044) for the treatment of moderate-to-severe Psoriasis (SOLARES PsO) and Atopic Dermatitis (SOLARES AD) failed to meet primary endpoint of 75 per cent improvement in Psoriasis Area and Severity Index (PASI).
"SPARC informs that its partner Sun Pharmaceutical Industries Limited (SPIL) announced the top-line results from the Phase 2 clinical trials evaluating Vibozilimod (SCD-044) for the treatment of moderate-to-severe Psoriasis (SOLARES PsO) and Atopic Dermatitis (SOLARES AD). SPIL informed that both SOLARES PsO and SOLARES AD studies did not meet the primary endpoint of 75 per cent improvement in PASI (Psoriasis Area and Severity Index) score (> PASI75) at Week 16 and 75 per cent improvement in EASI (Eczema Area and Severity Index) score (>EASI75) at Week 16 respectively," the filing read.
It added: SPARC and SPIL will evaluate the appropriate next steps for SCD-044.
Psoriasis is a chronic autoimmune condition characterised by skin inflammation and accelerated skin cell growth, resulting in raised, scaly patches called plaques, most commonly on the elbows, knees, scalp, and trunk.
Atopic dermatitis, also known as eczema, is a chronic inflammatory skin condition characterised by dry, itchy, and inflamed skin. It's a long-term condition that can cause patchy rashes and can occur at any age, though it often begins in childhood.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Mint
31 minutes ago
- Mint
IndusInd Bank share price jumps over 5% after RBI Governor says lender's issue should ‘settle down soon'
IndusInd Bank share price jumped over 5% after the Reserve Bank of India's (RBI) officials, including Governor Sanjay Malhotra, commented on the private lender's recent crisis. IndusInd Bank shares rallied as much as 5.32% to ₹ 845.85 apiece on the BSE. In its post-monetary policy press conference, RBI Governor Sanjay Malhotra said that the issue at the IndusInd Bank should settle down very soon. 'IndusInd Bank has taken enough steps to improve accounting practices. The issue in the bank should settle down very soon. The bank is doing well on the whole,' Malhotra said. IndusInd Bank MD & CEO has resigned, which was good enough, according to Malhotra. 'Law will take its course on IndusInd fraud. RBI will not be failing in its duty if any step has to be taken,' added Malhotra. RBI Deputy Governor J Swaminathan assured that there seems to be no systemic impact arising from the IndusInd Bank issue, while the central bank will keep monitoring the banking system.
The Print
32 minutes ago
- The Print
Markets log gains for 2nd day on fresh foreign fund inflows, buying in Reliance, ICICI Bank
After gaining over 900 points in the session, the 30-share BSE Sensex succumbed to profit booking to close 443.79 points or 0.55 per cent lower at 81,442.04. During the day, it jumped 912.88 points or 1.12 per cent to 81,911.13. Besides, expectations of another interest rate cut in the RBI policy on Friday supported market sentiment, traders said. Mumbai, Jun 5 (PTI) Benchmark equity indices Sensex and Nifty rallied for the second day on the trot on Thursday, driven by buying in blue-chip stocks ICICI Bank and Reliance Industries amid fresh foreign capital inflows. As many as 2,257 stocks advanced while 1,725 declined and 147 remained unchanged on the BSE. The NSE Nifty rose 130.70 points or 0.53 per cent to 24,750.90. 'Though profit-booking remains evident at higher levels, the benchmark indices are attempting to recover their momentum amid consolidation. With a weakening dollar index and volatile US bond yields, FIIs are turning net buyers again after the recent selloffs in anticipation of final trade negotiations. 'Despite global uncertainty, strong indicators of economic and corporate earnings growth are encouraging investors to adopt a buy-on-dip strategy. Moreover, markets are attentively awaiting upcoming central bank decisions, with a 25-bps rate cut anticipated from both the ECB and RBI,' Vinod Nair, Head of Research, Geojit Investments Limited, said. Eternal was the biggest gainer in the Sensex pack, jumping 4.50 per cent, followed by Power Grid, ICICI Bank, Reliance Industries, UltraTech Cement, Adani Ports, Sun Pharma, ITC and Hindustan Unilever were also among the winners. In contrast, IndusInd Bank, Axis Bank, Bajaj Finserv and Bajaj Finance were among the laggards. 'Markets witnessed volatility on the weekly expiry day but managed to close in the green. A lack of strong cues from global markets led to a flat start for the Nifty, followed by a swift recovery in the first half. However, profit-taking in the latter half significantly trimmed the gains…,' Ajit Mishra – SVP, Research, Religare Broking Ltd, said. Foreign Institutional Investors (FIIs) turned buyers on Wednesday, as they bought equities worth Rs 1,076.18 crore, according to exchange data. 'Nifty ended higher for the second straight session…Positive global cues and expectations of another interest rate cut in the RBI policy on Friday boosted market sentiment. 'FIIs returned as net buyers on Wednesday after two consecutive days of selling, pumping in Rs 1,076 crore into Indian equities. Renewed foreign inflows provided added comfort to the markets,' Siddhartha Khemka, Head of Research, Wealth Management, Motilal Oswal Financial Services Ltd, said. The BSE smallcap gauge climbed 0.65 per cent and the midcap index rallied 0.39 per cent. Among sectoral indices, realty jumped 1.79 per cent, services (1.09 per cent), healthcare (0.88 per cent), consumer discretionary (0.73 per cent), industrials (0.60 per cent), commodities (0.51 per cent) and financial services (0.43 per cent). On the other hand, auto and oil & gas were the laggards. In Asian markets, South Korea's Kospi, Shanghai's SSE Composite index and Hong Kong's Hang Seng settled in the positive territory while Japan's Nikkei 225 index ended lower. European markets were trading higher in mid-session deals. US markets ended on a mixed note on Wednesday. The Reserve Bank's rate-setting panel started its three-day brainstorming on monetary policy as expectations are high of a 25 bps or even a jumbo 50 bps rate cut to fuel economic growth amid uncertainties created by Trump's tariff moves. The decision of the Monetary Policy Committee (MPC), headed by Reserve Bank Governor Sanjay Malhotra, will be announced on Friday. Global oil benchmark Brent crude climbed 0.35 per cent to USD 65.14 a barrel. On Wednesday, the 30-share BSE Sensex climbed 260.74 points or 0.32 per cent to settle at 80,998.25. The Nifty went up 77.70 points or 0.32 per cent to 24,620.20. PTI SUM SUM BAL BAL This report is auto-generated from PTI news service. ThePrint holds no responsibility for its content.
Economic Times
34 minutes ago
- Economic Times
Bajaj Finance shares jump 5% after RBI cuts repo rate by 50 bps, CRR by 100 bps
Shares of Bajaj Finance jumped 5.5% to hit an intraday high of Rs 9,425.5 on the BSE in Friday's trade, as the Reserve Bank of India's 50 basis point repo rate cut and 100 basis point CRR cut sparked broad optimism in the lending sector, especially among non-banking financial companies (NBFCs). ADVERTISEMENT While the aggressive repo rate cut is expected to weigh on net interest margins (NIMs) for banks in the near term, the RBI's simultaneous move to reduce the Cash Reserve Ratio (CRR) by 100 bps, unlocking Rs 2.5 lakh crore of liquidity, has emerged as a game-changer for the credit ecosystem. For NBFCs like Bajaj Finance, which rely on borrowing from banks and capital markets to fund lending, this dual move of easing both rates and liquidity is expected to lower funding costs and support loan growth. Analysts noted that NBFCs stand to benefit disproportionately from the rate cut as falling interest rates reduce borrowing costs, enabling lenders to offer more competitive loan products and expand their credit books. Also read: RBI's bazooka sends Sensex, Nifty soaring. What does it mean for stock market investors 'This move is likely to enhance liquidity in the system, making borrowing cheaper and encouraging companies to pursue capital expenditure,' said Divam Sharma, Founder of Green Portfolio PMS. 'With FPI inflows slowing down, this infusion of liquidity is a timely and welcome move.' ADVERTISEMENT According to Arsh Mogre, Economist at PL Capital, 'By lowering both the price (repo) and quantity (CRR) of money, the RBI has flattened the transmission curve. The CRR cut in particular offsets short-term pressures on margins from falling lending rates.'For a lender like Bajaj Finance, improved liquidity and falling interest rates are likely to aid credit disbursal, support margins, and revive consumption-led demand, especially in retail and SME segments. ADVERTISEMENT 'Tailwinds for NIMs from improving systemic liquidity and deposit rate cuts are visible,' said Naveen Kulkarni, CIO at Axis Securities he said, even as H1FY26 will see a more pronounced impact of the rate cut on NIMs, some respite is expected over H2FY26. ADVERTISEMENT 'Asset quality concern appears to be steadily waning with unsecured segment stress showing gradual signs of stability, while the secured segment asset quality continues to hold up well. At present, we would prefer banks with promising growth prospects, healthy deposit franchises, stable asset quality metrics and strong and steady management teams.' Also read: RBI slashes rates by 50 bps: What it means for debt mutual fund investors ADVERTISEMENT With the RBI maintaining a neutral stance and indicating scope for further easing if inflation remains benign, NBFCs and banking companies could continue to benefit from the evolving rate cycle. (Disclaimer: Recommendations, suggestions, views and opinions given by the experts are their own. These do not represent the views of The Economic Times) (You can now subscribe to our ETMarkets WhatsApp channel)
